An alternative design for long-term stability testing of large molecules: a scientific discussion paper from an EBF Topic Team.

AIM Long-term stability testing of drug candidates in biological matrix is a key parameter in bioanalytical method validation. The European Bioanalysis Forum formed a Topic Team to evaluate the use of isochronic design for long-term stability testing of large molecules. METHOD Isochronic design is based on storage of samples at a reference temperature (below -130°C) where the samples are considered stable. The stability samples are stored at the intended storage temperature and then transferred to the reference temperature, while a set of reference samples is stored the entire storage period at the reference temperature. Stability and reference samples will then be analyzed in one run at the end of the storage period. The mean concentrations of the stability samples are compared either to their nominal concentrations or to the mean concentrations of the reference samples. CONCLUSION The design minimizes day-to-day variation, reduces workload and adds to the flexibility in the laboratory.

[1]  M. Toner,et al.  Long-term storage of tissues by cryopreservation: critical issues. , 1996, Biomaterials.

[2]  Thomas W Patapoff,et al.  Cold denaturation of monoclonal antibodies , 2010, mAbs.

[3]  Richard K Darst,et al.  Mechanistic elements of protein cold denaturation. , 2008, The journal of physical chemistry. B.

[4]  Eric Woolf,et al.  Best practices during bioanalytical method validation for the characterization of assay reagents and the evaluation of analyte stability in assay standards, quality controls, and study samples , 2007, The AAPS Journal.

[5]  K. Gallicano,et al.  Application issues in bioanalytical method validation, sample analysis and data reporting. , 1995, Journal of pharmaceutical and biomedical analysis.

[6]  Manish Yadav,et al.  Stability: Recommendation for Best Practices and Harmonization from the Global Bioanalysis Consortium Harmonization Team , 2014, The AAPS Journal.

[7]  Arjen Companjen,et al.  EBF recommendation for stability testing of anti-drug antibodies; lessons learned from anti-vaccine antibody stability studies. , 2014, Bioanalysis.

[8]  Stuart McDougall,et al.  Statistical methods for assessing long-term analyte stability in biological matrices. , 2009, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[9]  Martin Jørgensen,et al.  Evaluation of an isochronic study design for long-term frozen stability investigation of drugs in biological matrices. , 2010, Bioanalysis.

[10]  B. Yeung,et al.  Physical Stability of Protein Pharmaceuticals , 2010 .

[11]  Vinod P. Shah,et al.  Workshop/conference report—Quantitative bioanalytical methods validation and implementation: Best practices for chromatographic and ligand binding assays , 2007, The AAPS Journal.

[12]  D Dadgar,et al.  Issues in evaluation of bioanalytical method selectivity and drug stability. , 1995, Journal of pharmaceutical and biomedical analysis.

[13]  F. Franks,et al.  Stability of proteins at subzero temperatures: thermodynamics and some ecological consequences , 1991 .